Press releases and articles
01.07.19
Options Exercised by Takeda and AI Collaboration Extended
From collaboration to licensing options in less than 18 months
01.04.19
Recursion Signs Global Licensing Agreement
Contract signed with the Ohio State Innovation Foundation to Develop REC-2282 to Treat Neurofibromatosis Type 2
11.08.18
Recursion Secures $1.6M NIH Phase 2 SBIR Grant to Identify Therapeutic Candidates for Senescence, a Key Age-Related Disease Process
Recursion Secures $1.6M NIH Phase 2 SBIR Grant for Senescence
Events
05.16.18
Ron Alfa at AI in Healthcare, WPM18
Join Ron Alfa at AI in Healthcare, part of the 2018 World Precision Medicine Congress
05.22.18
Data Science Meetup: Lindsay (Anderson) Zuloaga
Please join us for our next Data Science Meetup!
Press resources

This section provides resources and assets for media partners and journalists looking for background information about Recursion Pharmaceuticals. In this section, you will find corporate descriptions, biographies of our founders, approved images, and logos. There are many stories to tell about our innovative approach to drug discovery. We welcome you to use this information as a starting point in your story development and reach out to us for interviews and specific details related to your areas of interest.